logo
Select company
Select metric
-60.68%Return on Invested Capital
VS
Market
14
Sector
40
Industry
53
History
-
$ 9.99Close
$ 5.54 - $ 18.57 52-Week Range
Ticker Information

Ticker

KURA

Company Name

KURA ONCOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

KURA ONCOLOGY INC - Return on Invested Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KURA - ROIC Historical data
DateInvested CapitalNet Income Common StockReturn on Invested Capital
6/30/2025$ 324.96M$ -197.17M-60.68%
3/31/2025$ 383.76M$ -181.89M-47.4%
12/31/2024$ 430.23M$ -173.98M-40.44%
9/30/2024$ 440.4M$ -197.55M-44.86%
6/30/2024$ 482.8M$ -181.75M-37.64%
3/31/2024$ 522.05M$ -168.09M-32.2%
12/31/2023$ 414.47M$ -152.63M-36.83%
9/30/2023$ 447.36M$ -142.96M-31.96%
6/30/2023$ 472.72M$ -139.86M-29.59%
3/31/2023$ 408.72M$ -137.46M-33.63%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KURA ONCOLOGY INC's latest trailing twelve months (TTM) ROIC stands at -25.41%.
  • Over the past 5 years, KURA ONCOLOGY INC's average ROIC has been -32.03%.
  • The median ROIC for KURA ONCOLOGY INC during this period was -31.58%
  • KURA ONCOLOGY INC reached its highest ROIC over the past 5 years at -14.37%.
  • The lowest ROIC recorded by KURA ONCOLOGY INC in the same timeframe -60.68%

KURA ONCOLOGY INC's ROIC vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROIC Benchmarks
CompanyROIC
SAGE : SAGE THERAPEUTICS INC -79.23%NKTR : NEKTAR THERAPEUTICS -169.95%YMAB : Y-MABS THERAPEUTICS INC -24.52%TBPH : THERAVANCE BIOPHARMA INC 4.8%ADCT : ADC THERAPEUTICS SA -LXRX : LEXICON PHARMACEUTICALS INC -65.01%ZVRA : ZEVRA THERAPEUTICS INC 1.47%GYRE : GYRE THERAPEUTICS INC 4.46%GOSS : GOSSAMER BIO INC -89.03%TRDA : ENTRADA THERAPEUTICS INC -16.89%

Definition of Return on Invested Capital

[Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Net Inc. Cmn. / Inv. Capital
(=) ROIC
ROIC for KURA ONCOLOGY INC is calculated as follows: Net Inc. Cmn. [ $ -81.33M ] / Inv. Capital [ $ 320.02M ]
(=) ROIC [ -25.41% ]

KURA - Return on Invested Capital, Last 5 years

-60.68%

Minimum

Jun 30, 2025

-14.37%

Maximum

Dec 31, 2020

-32.03%

Average

-31.58%

Median

ROIC Benchmark Analysis

The chart above depicts the distribution of ROIC for companies in the Total Stock Market. The average ROIC of the companies is 0.69% with a standard deviation of 15.18%.
The following table provides additional summary stats:
ROIC in the Market:
filtered constituents3.36K
min-46.36%
max48.66%
average0.69%
median3.38%
std15.18%